The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kasatkin D.S.

Yaroslavl State Medical University

Acute back pain: minimizing the risks of therapy as the basis for effective treatment

Authors:

Kasatkin D.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11): 80‑85

DOI: 10.17116/jnevro201911911180

Read: 993 times

Download PDF (RU)
Contact the author
Table of contents

ACUTE BACK PAIN: MINIMIZING THE RISKS OF THERAPY AS THE BASIS FOR EFFECTIVE TREATMENT
ACUTE BACK PAIN: MINIMIZING THE RISKS OF THERAPY AS THE BASIS FOR EFFECTIVE TREATMENT

To cite this article:

Kasatkin DS. Acute back pain: minimizing the risks of therapy as the basis for effective treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11):80‑85. (In Russ.)
https://doi.org/10.17116/jnevro201911911180

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Dorsopathies are one of the most common pathologies in the practice of a neurologist and therapist. Lower back pain as a leader in years lived with disability. Clinical differential diagnosis using red flags can significantly reduce the proportion of patients with unreasonable examinations. Stratifying patients for the risk of chronic pain and delayed recovery also reduces the risks of prolonged NSAID therapy. Identification of risk groups for cardiovascular and gastrointestinal complications and differentiated prescription of drugs helps to reduce the risks of therapy.

Keywords:

low back pain
non-steroidal anti-inflammatory drugs
risk stratification
aceclofenac

Authors:

Kasatkin D.S.

Yaroslavl State Medical University

Received:

26.08.2019

Accepted:

27.09.2019

Close metadata

References:

  1. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, Williams G, Smith E, Vos T, Barendregt J, Murray C, Burstein R, Buchbinder R. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:968-974.  https://doi.org/10.1136/annrheumdis-2013-204428
  2. Hoy D, Bain C, Williams G, March L, Brooks P, Blyth F, Woolf A, Vos T, Buchbinder R. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64(6):2028-2037. https://doi.org/10.1002/art.34347
  3. Calvo-Muñoz I, Gómez-Conesa A, Sánchez-Meca J. Prevalence of low back pain in children and adolescents: a meta-analysis. BMC Pediatr. 2013;13:14.  https://doi.org/10.1186/1471-2431-13-14
  4. Taimela S, Kujala UM, Salminen JJ, Viljanen T. The prevalence of low back pain among children and adolescents. A nationwide, cohort-based questionnaire survey in Finland. Spine (Phila Pa 1976). 1997;22(10):1132-1136.
  5. Junqueira DR, Ferreira ML, Refshauge K, Maher CG, Hopper JL, Hancock M, Carvalho MG, Ferreira PH. Heritability and lifestyle factors in chronic low back pain: results of the Australian twin low back pain study (The AUTBACK study). Eur J Pain. 2014;18(10):1410-1418. https://doi.org/10.1002/ejp.506
  6. Taylor JB, Goode AP, George SZ, Cook CE. Incidence and risk factors for first-time incident low back pain: a systematic review and meta-analysis. Spine J. 2014;14(10):2299-2319. https://doi.org/10.1016/j.spinee.2014.01.026
  7. Steffens D, Ferreira ML, Latimer J, Ferreira PH, Koes BW, Blyth F, Li Q, Maher CG. What triggers an episode of acute low back pain? A case-crossover study. Arthritis Care Res. (Hoboken). 2015;67(3):403-410.  https://doi.org/10.1002/acr.22533
  8. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075-2094. https://doi.org/10.1007/s00586-010-1502-y
  9. Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, Macaskill P, Irwig L, van Tulder MW, Koes BW, Maher CG. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ. 2013;347:f7095. https://doi.org/10.1136/bmj.f7095
  10. Henschke N, Maher CG, Refshauge KM, Herbert RD, Cumming RG, Bleasel J, York J, Das A, McAuley JH. Prevalence of and screening for serious spinal pathology in patients presenting to primary care settings with acute low back pain. Arthritis Rheum. 2009;60(10):3072-3080. https://doi.org/10.1002/art.24853
  11. Galukande M, Muwazi S, Mugisa DB. Aetiology of low back pain in Mulago Hospital, Uganda. Afr Health Sci. 2005;5(2):164-167. PMID: 16006225.
  12. Parfenov VA, Ivanova MA. General practitioners’ management of patients with back pain. Medicinskij Sovet. 2018;1:112-117. (In Russ.). https://doi.org/10.21518/2079-701X-2018-1-112-117
  13. Roman M, Brown C, Richardson W, Isaacs R, Howes C, Cook C. The development of a clinical decision making algorithm for detection of osteoporotic vertebral compression fracture or wedge deformity. J Man Manip Ther. 2010;18(1):44-49.  https://doi.org/10.1179/106698110X12595770849641
  14. Henschke N, Maher CG, Ostelo RW, de Vet HC, Macaskill P, Irwig L. Red flags to screen for malignancy in patients with low-back pain. Cochrane Database Syst Rev. 2013;2:CD008686. https://doi.org/10.1002/14651858.CD008686.pub2
  15. Verhagen AP, Downie A, Maher CG, Koes BW. Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review. Pain. 2017;158(10):1860-1868. https://doi.org/10.1097/j.pain.0000000000000998
  16. Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg. 1988;16:121-176. PMID: 3064753.
  17. Underwood M. Diagnosing acute nonspecific low back pain: time to lower the red flags? Arthritis Rheum. 2009;60(10):2855-2857. https://doi.org/10.1002/art.24858
  18. Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet. 2009;373(9662):463-472.  https://doi.org/10.1016/S0140-6736(09)60172-0
  19. Brinjikji W, Luetmer PH, Comstock B, Bresnahan BW, Chen LE, Deyo RA, Halabi S, Turner JA, Avins AL, James K, Wald JT, Kallmes DF, Jarvik JG. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811-816.  https://doi.org/10.3174/ajnr.A4173
  20. Downie AS, Hancock MJ, Rzewuska M, Williams CM, Lin CW, Maher CG. Trajectories of acute low back pain: a latent class growth analysis. Pain. 2016;157(1):225-234.  https://doi.org/10.1097/j.pain.0000000000000351
  21. Almeida M, Saragiotto B, Richards B, Maher CG. Primary care management of non-specific low back pain: key messages from recent clinical guidelines. Med J Aust. 2018;208(6):272-275.  https://doi.org/10.5694/mja17.01152
  22. Wertli MM, Rasmussen-Barr E, Weiser S, Bachmann LM, Brunner F. The role of fear avoidance beliefs as a prognostic factor for outcome in patients with nonspecific low back pain: a systematic review. Spine J. 2014;14(5):816-836.e4.  https://doi.org/10.1016/j.spinee.2013.09.036
  23. Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA. 2010;303(13):1295-1302. https://doi.org/10.1001/jama.2010.344
  24. Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, Konstantinou K, Main CJ, Mason E, Somerville S, Sowden G, Vohora K, Hay EM. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomisedcontrolled trial. Lancet. 2011;378(9802):1560-1571. https://doi.org/10.1016/S0140-6736(11)60937-9
  25. Hayden JA, Chou R, Hogg-Johnson S, Bombardier C. Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol. 2009;62(8):781-796.e1.  https://doi.org/10.1016/j.jclinepi.2008.09.004
  26. Kasatkin DS. Pain and muscle spasm: justification of myorelaxant treatment in patients with pain. Klin Farmakologija i Terapija. 2011;5:75-78. (In Russ.).
  27. Scarpignato C, Lanas A, Blandizzi C, Lems WF, Hermann M, Hunt RH; International NSAID Consensus Group. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis — an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13:55.  https://doi.org/10.1186/s12916-015-0285-8
  28. Chou R, Côté P, Randhawa K, Torres P, Yu H, Nordin M, Hurwitz EL, Haldeman S, Cedraschi C. The Global Spine Care Initiative: applying evidence-based guidelines on the non-invasive management of back and neck pain to low- and middle-income communities. Eur Spine J. 2018;27(suppl 6):851-860.  https://doi.org/10.1007/s00586-017-5433-8
  29. Kasatkin DS. Place of selective inhibitors of cox-2 in therapy of acute and chronic pain. Bol’. 2008;2:33-38. (In Russ.).
  30. Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010;69(8):1453-1458. https://doi.org/10.1136/ard.2009.123166
  31. Nasonov EL, Karateev AE. Stomach lesions associated with taking non-steroidal anti-inflammatory drugs. Klin Med. 2000;3:4-9. (In Russ.).
  32. Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S.; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127-1146. https://doi.org/10.2165/11633470-000000000-00000
  33. Karateev AE, Misiyuk AS. Nonsteroidal anti-inflammatory drugs as the first step in treating musculoskeletal pain. Sovremennaja Revmatologija. 2015;3:61-69. (In Russ.).
  34. Patel PB, Patel TK. Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials. Eur J Rheumatol. 2017;4(1):11-18. 
  35. Kasatkin DS. The place of selective cyclooxygenase type 2 inhibitors in the treatment of acute and chronic pain. Neurology and Rheumatology («Consilium Medicum»). 2008;1:67-71. (In Russ.).
  36. Saraf S. Aceclofenac: A. Potent NonSteroidal Anti-Inflammatory Drug in Latest Reviews. Latest Rev. 2006;4(3):43-46. 
  37. Yang JH, Suk KS, Lee BH, Jung WC, Kang YM, Kim JH, Kim HS, Lee HM, Moon SH. Efficacy and Safety of Different Aceclofenac Treatments for Chronic Lower Back Pain: Prospective, Randomized, Single Center, Open-Label Clinical Trials. Yonsei Med J. 2017;58(3):637-643.  https://doi.org/10.3349/ymj.2017.58.3.637
  38. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis. 2018;9(1):143-150.  https://doi.org/10.14336/AD.2017.0306
  39. Masclee GMC, Straatman H, Arfè A, Castellsague J, Garbe E, Herings R, Kollhorst B, Lucchi S, Perez-Gutthann S, Romio S, Schade R, Schink T, Schuemie MJ, Scotti L, Varas-Lorenzo C, Valkhoff VE, Villa M, Sturkenboom MCJM. Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project. PLoS One. 2018;13(11):e0204746. https://doi.org/10.1371/journal.pone.0204746
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.